RE:RE:RE:RE:EU Legislative proposals aims to expedite new medicinesAs of April 11, 2024 we now have the various international regulatory bodies "pulling" in the same direction for the potential of ONCY's pelareorep's Accelerated Approval, and these positive legislative changes aspirationally aligns with ONCY's putative near-term acquisition by Big Pharma.